Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 17, 2025 15:01 ET | Source: Grabar Law Office

Notice to Long-Term Shareholders of Fluence Energy, Inc. (NASDAQ: FLNC); Kyverna Therapuetics, Inc. (NASDAQ: KYTX); Mercury Systems, Inc. (NASDAQ: MRCY); and Sage Therapeutics, Inc. (NASDAQ: SAGE): Grabar Law Office Is Investigating Claims on Your Behalf

PHILADELPHIA, March 17, 2025 (GLOBE NEWSWIRE) -- Fluence Energy, Inc. (NASDAQ: FLNC): Grabar Law Office is investigating claims on behalf of Fluence Energy, Inc. (NASDAQ: FLNC) shareholders. The...
March 14, 2025 13:29 ET | Source: Grabar Law Office

Notice to Long-Term Shareholders of Mercury Systems, Inc. (NASDAQ: MRCY); Methode Electronics, Inc. (NYSE: MEI); Monolithic Power Systems, Inc. (NASDAQ: MPWR); and Sage Therapeutics, Inc. (NASDAQ: SAGE): Grabar Law Office Investigates Claims on Your Behalf

PHILADELPHIA, March 14, 2025 (GLOBE NEWSWIRE) -- Mercury Systems, Inc. (NASDAQ: MRCY) Class Action Survives Motion to Dismiss: A securities fraud class action complaint against Mercury Systems,...
March 13, 2025 18:21 ET | Source: Grabar Law Office

Long-Term Shareholder Notice: Fluence Energy, Inc. (NASDAQ: FLNC); Kyverna Therapuetics, Inc. (NASDAQ: KYTX); Mercury Systems, Inc. (NASDAQ: MRCY); and Sage Therapeutics, Inc. (NASDAQ: SAGE): Grabar Law Office Investigates Claims on Your Behalf

PHILADELPHIA, March 13, 2025 (GLOBE NEWSWIRE) -- Fluence Energy, Inc. (NASDAQ: FLNC): Grabar Law Office is investigating claims on behalf of Fluence Energy, Inc. (NASDAQ: FLNC) shareholders. The...
March 12, 2025 08:26 ET | Source: Grabar Law Office

Long-Term Shareholder Notice: Driven Brands Holdings, Inc. (NASDAQ: DRVN); Mercury Systems, Inc. (NASDAQ: MRCY); Playstudios, Inc. (NASDAQ: MYPS); and Sage Therapeutics, Inc. (NASDAQ: SAGE): Grabar Law Office Investigates Claims on Your Behalf

PHILADELPHIA, March 12, 2025 (GLOBE NEWSWIRE) -- Driven Brands Holdings, Inc. (NASDAQ: DRVN) Class Action Survives Motion to Dismiss: A securities fraud class action complaint against Driven...
March 10, 2025 08:05 ET | Source: Grabar Law Office

Attention Long-Term Shareholders of Driven Brands Holdings, Inc. (NASDAQ: DRVN); Mercury Systems, Inc. (NASDAQ: MRCY); Playstudios, Inc. (NASDAQ: MYPS); and Sage Therapeutics, Inc. (NASDAQ: SAGE): Grabar Law Office Investigates Claims on Your Behalf as Certain Class Actions Move Forward

PHILADELPHIA, March 10, 2025 (GLOBE NEWSWIRE) -- Driven Brands Holdings, Inc. (NASDAQ: DRVN) Class Action Survives Motion to Dismiss: Grabar Law Office is investigating claims on behalf of...
January 24, 2025 13:38 ET | Source: KUEHN LAW, PLLC

Kuehn Law Encourages Investors of Sage Therapeutics, Inc. to Contact Law Firm

Kuehn Law is investigating Sage Therapeutics, Inc. for potential fiduciary breaches by its officers and directors, urging shareholders to contact.
October 23, 2024 20:06 ET | Source: Portnoy Law

Sage Therapeutics, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. October 28, 2024 Deadline to file Lead Plaintiff Motion

LOS ANGELES, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Investors can contact the law firm at no cost to learn more about recovering their losses The Portnoy Law Firm advises Sage Therapeutics, Inc....
October 21, 2024 16:43 ET | Source: Portnoy Law

Sage Therapeutics, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. October 28, 2024 Deadline to file Lead Plaintiff Motion

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Oct. 21, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Sage Therapeutics, Inc. ("Sage"...
October 04, 2024 20:18 ET | Source: Robbins LLP

SAGE REMINDER – Robbins LLP Urges SAGE Investors to Obtain Legal Counsel in Light of the Pending Lead Plaintiff Deadline

Robbins LLP is Investigating Allegations that Sage Therapeutics, Inc. (SAGE) Misled Investors Regarding the Efficacy of its New Drugs
September 17, 2024 19:45 ET | Source: Robbins LLP

SAGE CLASS ACTION: Sage Therapeutics, Inc. Stockholders Should Contact Robbins LLP for Information About the Securities Class Action Lawsuit

Robbins LLP is Investigating Allegations that Sage Therapeutics, Inc. (SAGE) Misled Investors Regarding the Efficacy of its New Drugs

Next Page keyboard_arrow_right